Delcath Systems Inc (DCTH)
5.725
+0.14
(+2.60%)
USD |
NASDAQ |
May 10, 16:00
5.725
0.00 (0.00%)
After-Hours: 18:01
Delcath Systems Enterprise Value: 119.65M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 09, 2024 | 119.65M |
May 08, 2024 | 117.99M |
May 07, 2024 | 122.95M |
May 06, 2024 | 124.48M |
May 03, 2024 | 119.14M |
May 02, 2024 | 116.09M |
May 01, 2024 | 115.07M |
April 30, 2024 | 109.98M |
April 29, 2024 | 110.23M |
April 26, 2024 | 112.52M |
April 25, 2024 | 111.51M |
April 24, 2024 | 116.34M |
April 23, 2024 | 120.16M |
April 22, 2024 | 117.87M |
April 19, 2024 | 101.59M |
April 18, 2024 | 97.13M |
April 17, 2024 | 91.54M |
April 16, 2024 | 98.02M |
April 15, 2024 | 101.59M |
April 12, 2024 | 103.62M |
April 11, 2024 | 104.89M |
April 10, 2024 | 104.89M |
April 09, 2024 | 104.13M |
April 08, 2024 | 105.91M |
April 05, 2024 | 104.89M |
Date | Value |
---|---|
April 04, 2024 | 105.66M |
April 03, 2024 | 101.59M |
April 02, 2024 | 97.26M |
April 01, 2024 | 99.55M |
March 28, 2024 | 99.04M |
March 27, 2024 | 107.18M |
March 26, 2024 | 94.97M |
March 25, 2024 | 96.24M |
March 22, 2024 | 96.75M |
March 21, 2024 | 96.50M |
March 20, 2024 | 85.81M |
March 19, 2024 | 86.58M |
March 18, 2024 | 80.37M |
March 15, 2024 | 68.06M |
March 14, 2024 | 62.37M |
March 13, 2024 | 64.87M |
March 12, 2024 | 65.21M |
March 11, 2024 | 66.01M |
March 08, 2024 | 68.40M |
March 07, 2024 | 68.51M |
March 06, 2024 | 66.47M |
March 05, 2024 | 67.49M |
March 04, 2024 | 72.84M |
March 01, 2024 | 73.07M |
February 29, 2024 | 72.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.67M
Minimum
Dec 30 2019
124.48M
Maximum
May 06 2024
41.81M
Average
43.28M
Median
Jan 05 2023
Enterprise Value Benchmarks
Star Equity Holdings Inc | 12.44M |
Exact Sciences Corp | 11.71B |
Illumina Inc | 18.12B |
CytoSorbents Corp | 34.50M |
Progyny Inc | 2.765B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -11.14M |
Revenue (Quarterly) | 0.539M |
Total Expenses (Quarterly) | 11.84M |
EPS Diluted (Quarterly) | -0.33 |
Gross Profit Margin (Quarterly) | 68.27% |
Profit Margin (Quarterly) | -2.07K% |
Earnings Yield | -49.26% |
Normalized Earnings Yield | -41.88 |